2024
Maternal and Newborn Outcomes of SARS-CoV-2/COVID-19 and Pregnancy: Parallels and Contrasts with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
Li D, Zhang J, Zhang X, Chang Y, Vermund S. Maternal and Newborn Outcomes of SARS-CoV-2/COVID-19 and Pregnancy: Parallels and Contrasts with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Medical Research Archives 2024, 12: 10.18103/mra.v12i4.5205. PMID: 39118854, PMCID: PMC11309002, DOI: 10.18103/mra.v12i4.5205.Peer-Reviewed Original ResearchHuman immunodeficiency virus/acquired immunodeficiency syndromeHuman immunodeficiency virusHuman immunodeficiency virus-infected womenAdherence to antiretroviral therapyNeonatal outcomesImmunodeficiency virusImmunodeficiency syndromeIntensive care unitAntiretroviral therapySARS-CoV-2Maternal mortalityRisk of mother-to-child transmissionVertical transmissionVertical transmission of human immunodeficiency virusClinical managementTransmission of human immunodeficiency virusImpact of human immunodeficiency virusIncreased risk of maternal mortalityHuman immunodeficiency virus controlPoor adherence to antiretroviral therapySARS-CoV-2 vertical transmissionVertical transmission of SARS-CoV-2Pregnant individualsMother-to-child transmissionNeonatal intensive care unit
2018
Severe outcomes associated with respiratory viruses in newborns and infants: a prospective viral surveillance study in Jordan
Khuri-Bulos N, Lawrence L, Piya B, Wang L, Fonnesbeck C, Faouri S, Shehabi A, Vermund SH, Williams JV, Halasa NB. Severe outcomes associated with respiratory viruses in newborns and infants: a prospective viral surveillance study in Jordan. BMJ Open 2018, 8: e021898. PMID: 29780032, PMCID: PMC5961648, DOI: 10.1136/bmjopen-2018-021898.Peer-Reviewed Original ResearchMeSH KeywordsAdenoviridaeAntiviral AgentsFemaleHumansInfantIntensive Care UnitsJordanLength of StayMaleOxygen Inhalation TherapyPalivizumabParainfluenza Virus 1, HumanProspective StudiesRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesRespiratory Syncytial Virus, HumanRespiratory Tract InfectionsRhinovirusRisk FactorsConceptsLonger LOSLength of stayAcute respiratory infectionsIntensive care unitRespiratory syncytial virusOxygen therapyMechanical ventilationHospitalisation ratesICU admissionIllness severityRespiratory virusesMedical conditionsExtended breast feedingRSV vaccine developmentProspective cohort studyUnderlying medical conditionsChemotherapy-associated neutropeniaHuman parainfluenza virusesYears of ageCohort studyRespiratory symptomsBreast feedingRespiratory infectionsCare unitSyncytial virus
2010
Burden of respiratory syncytial virus in hospitalized infants and young children in Amman, Jordan
Khuri-Bulos N, Williams JV, Shehabi AA, Faouri S, Al Jundi E, Abushariah O, Chen Q, Ali SA, Vermund S, Halasa NB. Burden of respiratory syncytial virus in hospitalized infants and young children in Amman, Jordan. Infectious Diseases 2010, 42: 368-374. PMID: 20100116, PMCID: PMC2854220, DOI: 10.3109/00365540903496544.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsCost of IllnessFemaleHospitalizationHumansInfantJordanLength of StayMaleMiddle EastNosePharynxPrevalenceProspective StudiesRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanReverse Transcriptase Polymerase Chain ReactionRNA, ViralSex FactorsUnited StatesConceptsAcute respiratory infectionsMedian ageNose/throat swabsRespiratory syncytial virus seasonChildren's median ageRSV-negative childrenRSV-positive childrenSpecific viral causeLonger hospital stayHigher hospital chargesIntensive care unitRespiratory syncytial virusReal-time polymerase chain reactionLower median ageEffective preventive measuresJordanian infantsHospital stayHospitalized infantsRSV vaccineRespiratory infectionsCare unitHospital chargesSyncytial virusThroat swabsViral cause